Corrective Assignment to Correct the the Assignees Address Previously Recorded at Reel: 063697 Frame: 0106. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2023-05-24 Pages: 6

Assignor

ANTIGEN EXPRESS, INC

Executed: 2019-12-27

Assignee

NUGENEREX IMMUNO-ONCOLOGY, INC.

450 CENTURY PKWY, SUITE 250, ALLEN, TEXAS, 75013

Covered Property (1)

Ii-Key/Antigenic Epitope Hybrid Peptide Vaccines

Patent: 9,289,487 →

Application: 11/033,039 →

Publication: US 2006/0002947

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.